| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/22/2004 | WO2002070729A3 Improved skin substitutes and uses thereof |
| 01/22/2004 | US20040016029 Growing a transgenic plant or plant seed transformed with a DNA molecule which encodes for a hypersensitive response elicitor protein or polypeptide |
| 01/22/2004 | US20040016023 Modification of plant cell wall component and method of regulating development differentiation |
| 01/22/2004 | US20040016020 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/22/2004 | US20040016011 Mouse model for inducing hepatocellular carcinoma by targeted integration of hepatitis B virus genes |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014942 Transformation cells by introduction of a false-sense mutation at a target codon of a gene coding for a protein necessary for the growth of the cells, such protein synthesized from the gene thus mutated is non functional |
| 01/22/2004 | US20040014814 A method of altering the senescence of cells comprising applying to said cells an effective amount of a composition wherein said composition includes N-acetyl-carnosine as an active ingredient. |
| 01/22/2004 | US20040014738 Method of inactivating micro-organisms |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014662 Modulation of neural stem cells and neural progenitor cells |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014601 Adjust concentration of plant protein using peracetic acid, salicylic acid; gene encoding transcription factor |
| 01/22/2004 | US20040014220 Using electroporation to transfer nucleotide sequences and biologicaly active molecules into peripheral human blood cells; gene therapy |
| 01/22/2004 | US20040014219 Comprises expression vector coding fusion protein associated cell proliferation and/or differentiation; gene therapy; animal model for disease |
| 01/22/2004 | US20040014218 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 01/22/2004 | US20040014216 Using internal ribosome entry sites (IRES) to identifying and characterizing transcriptionally active regions in plants; tissue engineering; transgenic seeds |
| 01/22/2004 | US20040014215 Preparing cocurrent plant cultures and isolating cell cycle regulated genes or proteins |
| 01/22/2004 | US20040014214 Method for producing a recipient-specific tissue transplant |
| 01/22/2004 | US20040014213 Selected cell delivery for heart failure |
| 01/22/2004 | US20040014212 Culturing pancreatic tissues for treatment of diabetes; animal models; tissue engineering |
| 01/22/2004 | US20040014211 Meningeal-derived stem cells |
| 01/22/2004 | US20040014210 Stimulating conversion of progenitor cells into neuronal cells for treatment of nervous system and spinal cord disorders; tissue engineering |
| 01/22/2004 | US20040014209 Stimulating conversion of stem cells into cardiac cells using modulators of anteriorposterior patterning for grafting and treatment of heart diseases and defects; peptidomimetics |
| 01/22/2004 | US20040014208 Methods for culturing human lung mast cells and uses thereof |
| 01/22/2004 | US20040014206 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/22/2004 | US20040014205 Propagating cells on three dimensional array; tissue engineering; organ repair and/or replacement |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014177 Using leukemia cells as bioreactor for production of heterologous protein; gene therapy |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014151 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 01/22/2004 | US20040014138 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 01/22/2004 | US20040014136 Crystal structure of complement inhibitor (sCR1) for preventing hemolysis, necrosis and tissue destruction |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014092 Production of transgenic plants which synthesize long-chain inulin due to the introduction of nucleic acid molecules encoding a fructosyl transferase |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014046 Preparing candidate vaccine agents based on a polypeptide comprising an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide that induces an immune response |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040014031 Improved packaging cell-lines and methods for the production of recombinant Adeno-Associated Viruses (rAAV); can be used in a number of applications necessitating the over-expression of a gene in a cell |
| 01/22/2004 | US20040013740 Antitumor agents for treating tumor of mucosa, skin; poisons are selected from scolopenders, snakes, spiders or scorpions |
| 01/22/2004 | US20040013719 Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules |
| 01/22/2004 | US20040013712 Collagen membrane arranged at macromolecular level |
| 01/22/2004 | US20040013687 Complexing Clostridium botulinum; translocation; induction immunology response |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013676 Administering dosage of mature dendritic cells in carrier |
| 01/22/2004 | US20040013672 Recombinant antibodies, and compositions and methods for making and using the same |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013661 Gene controlling peptide; antiinflammatory agents |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | DE10228187A1 Testsystem zum Nachweis von Krebserkrankungen Test system for the detection of cancer |
| 01/22/2004 | DE10227606B3 Verwendung von Thrombopoietin zur Kultivierung von Hepatozyten Use of thrombopoietin for culturing hepatocytes |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2532418A1 Method for preparing engineered tissue |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2493871A1 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | CA2493849A1 Methods and systems for extended in vitro culture of neuronal cells |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492601A1 Methods for inducing differentiation of embryonic stem cells and uses thereof |
| 01/22/2004 | CA2492469A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 01/22/2004 | CA2492383A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/22/2004 | CA2492364A1 High yielding soybean plants with increased seed protein plus oil |
| 01/22/2004 | CA2492267A1 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 01/22/2004 | CA2491320A1 Methods and compositions for modulating t helper (th) cell development and function |
| 01/22/2004 | CA2489203A1 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382674A2 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 01/21/2004 | EP1382673A1 Method of culturing collected biopsy cells |
| 01/21/2004 | EP1382672A1 Small liver cell-rich colony, method of preparing the same, method of maturing the same into liver tissue and method of estimating drug function using the matured small liver cell-rich colony |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1382346A1 Conditioned medium and diffusible biological product produced by incubating entrapped cells |
| 01/21/2004 | EP1381866A2 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381684A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/21/2004 | EP1381681A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/21/2004 | EP1381680A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381677A2 Neurotoxins with enhanced target specificity |
| 01/21/2004 | EP1381676A2 Nucleic acid molecules encoding starch degrading enzymes |
| 01/21/2004 | EP1381675A2 Method for replicating the hepatitis c virus |
| 01/21/2004 | EP1381674A2 Method for generating highly active human dendritic cells from monocytes |
| 01/21/2004 | EP1381673A1 Compositiona and methods useful for hcv infection |
| 01/21/2004 | EP1381631A2 Human timp-1 antibodies |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381625A1 Mutants of green fluorescent protein |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381410A2 Methods of isolating blood components using a centrifuge and uses thereof |